Question

What do Phase 2 clinical trials assess for?

a. Safety
b. Efficiency
c. Dosage
d. Chemistry

Answer 1

Phase 2 clinical trials assess the safety, efficiency, and dosage of a drug candidate.

Step-by-step explanation:

In Phase 2 clinical trials, several assessments are conducted to gather information about a new drug candidate. These assessments include:

1. Safety: Phase 2 trials assess the safety profile of the drug in a larger group of patients compared to Phase 1 trials. This helps to identify any potential side effects or adverse reactions.
2. Efficiency: Phase 2 trials evaluate the efficacy of the drug in treating the targeted condition or disease. This involves measuring the drug's effectiveness in achieving the desired therapeutic outcomes.
3. Dosage: Phase 2 trials also involve determining the appropriate dosage range for the drug. This helps to establish the most effective and safe doses for further testing in Phase 3 trials.
4. Chemistry: While chemistry-related assessments may be carried out during the drug discovery and development process, they are not specifically part of Phase 2 clinical trials.